- Home
- / Amplia Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Amplia Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.2
2024-10-18
Market Capitalization
$42.6 M
2024-10-18
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| NZD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 643.0K | 50.0K | 34.0K | 1.6M | 2.0M | 1.2M | 4.5M | 3.8M |
| Operating expense total | 4.8M | 2.0M | 2.3M | 3.9M | 5.6M | 7.4M | 8.9M | 10.5M |
| Depreciation and amortization | 19.0K | 2.0K | 1.0K | 1.0K | 3.0K | 73.0K | 86.0K | 85.0K |
| EBITDA | (4.2M) | (1.9M) | (2.2M) | (2.3M) | (3.6M) | (6.2M) | (4.5M) | (6.7M) |
| EBIT | (4.2M) | (1.9M) | (2.2M) | (2.3M) | (3.6M) | (6.3M) | (4.6M) | (6.8M) |
| Interest income | 27.0K | 20.0K | 4.0K | 1.0K | 1.0K | 97.0K | 145.0K | 276.0K |
| Interest expense | 1.0K | 54.0K | 78.0K | 56.0K | ||||
| Pre tax profit | (4.3M) | (1.9M) | (2.2M) | (2.3M) | (3.6M) | (6.2M) | (4.5M) | (6.6M) |
| Net Income | (4.3M) | (1.9M) | (2.2M) | (2.3M) | (3.6M) | (6.2M) | (4.5M) | (6.6M) |